IN VITRO IMMUNOSUPPRESSIVE EFFECTS OF FR 900506 ON HUMAN T LYMPHOCYTE ALLOACTIVATION
- PMID: 21552396
- PMCID: PMC3089009
IN VITRO IMMUNOSUPPRESSIVE EFFECTS OF FR 900506 ON HUMAN T LYMPHOCYTE ALLOACTIVATION
Abstract
FR 900506 (FR) is a new immunosuppressive drug which prolongs allograft survival. Our studies have compared the in vitro inhibitory effects of FR and Cyclosporine (CsA) on human lymphocyte proliferation. Considerably lower doses of FR were required to induce inhibition of lymphocyte proliferation induced by concanavalin A (ConA) stimulation or in primary mixed lymphocyte reactions (MLR) Similar differences between FR and CsA were observed with the secondary stimulation of alloactivated T cells generated in MLR or propagated from liver transplant biopsies These observations provide further evidence that FR is about 500 fold more potent than CsA and may be a useful immunosuppressive agent in organ transplantation.
Figures




Similar articles
-
Comparative Inhibitory Effects of Tacrolimus, Cyclosporine, and Rapamycin on Human Anti-Pig Xenogeneic Mixed Lymphocyte Reactions.Xenotransplantation. 2024 Jul-Aug;31(4):e12876. doi: 10.1111/xen.12876. Xenotransplantation. 2024. PMID: 39031102
-
Significant prolongation of animal survival by combined therapy of FR167653 and cyclosporine A in rat renal allografts.Transplantation. 2003 Oct 15;76(7):1029-36. doi: 10.1097/01.TP.0000090392.56694.06. Transplantation. 2003. PMID: 14557748
-
Cyclosporin A metabolites suppress T-cell proliferation by concanavalin A and in a mixed lymphocyte reaction.Can J Surg. 1988 May;31(3):145-50. Can J Surg. 1988. PMID: 2966666
-
The immunosuppressive macrolides FK-506 and rapamycin.Immunol Lett. 1991 Jul;29(1-2):105-11. doi: 10.1016/0165-2478(91)90209-s. Immunol Lett. 1991. PMID: 1717376 Review.
-
Immunosuppressive agents in organ transplantation: past, present, and future.Semin Nephrol. 2000 Mar;20(2):108-25. Semin Nephrol. 2000. PMID: 10746855 Review.
Cited by
-
In Vitro Immunosuppressive Effects of FK506 in Combination With Other Drugs.Transplant Proc. 1988 Feb 1;20(1 suppl 1):220-222. Transplant Proc. 1988. PMID: 21307965 Free PMC article. No abstract available.
-
Species differences in sensitivity of T lymphocytes to immunosuppressive effects of FK 506.Transplantation. 1990 Jun;49(6):1170-2. doi: 10.1097/00007890-199006000-00029. Transplantation. 1990. PMID: 1694318 Free PMC article. No abstract available.
-
Incidence and treatment of rejection episodes in primary orthotopic liver transplantation under FK 506.Transplant Proc. 1991 Feb;23(1 Pt 2):928-30. Transplant Proc. 1991. PMID: 1703354 Free PMC article.
-
Effect of FK506 in experimental organ transplantation.Transplant Proc. 1988 Feb;20(1 Suppl 1):215-9. Transplant Proc. 1988. PMID: 2450416 Free PMC article.
-
Immunosuppression of canine, monkey, and baboon allografts by FK 506: with special reference to synergism with other drugs and to tolerance induction.Surgery. 1988 Aug;104(2):239-49. Surgery. 1988. PMID: 2456627 Free PMC article.
References
-
- OCHIAI T, NAKAJIMA K, NAGATA M, SUZUKI T, ASANO T, UEMATSU T, GOTO T, HORI S, HENMOCHI T, NAKAGOORI T, ISONO K. Effect of a new immunosuppresive agent, FK 506, on heterotopic cardiac allotransplantation in the rat. Transplant Proc. 1987;19:1284–1286. - PubMed
-
- ZEEVI A, DUQUESNOY R. Specificity of alloactivated human T lymphocyte clones in secondary proliferation, cell-mediated lympholysis and Interleukin 2 release. J Immunogenet. 1985;12:17–31. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources